UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

174 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-21

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

UNCOVER is a non-interventional study to investigate the prevalence of difficult-to-treat and severe Asthma eligible for treatment with biologics in a cohort of patients with suspected, so far undiagnosed severe Asthma which were previously treated by General practitioners and Office-based pulmonologists.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

NCT06299306

Asthma, Bronchial

TERMINATED

Experience of Biologic Treatments for Severe Asthma: a Survey

NCT06903780

Severe Asthma

RECRUITING

This is a 6-month Observational Study. Patients Included Will be Those Referred With a Possible Diagnosis or an Established Diagnosis of Asthma. It Will Look at the Association of the Asthma Microbiome and Disease Characteristics, Severity and Treatment Response.

NCT06028204

Asthma

UNKNOWN

A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

NCT04808518

Asthma

COMPLETED

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

NCT06102005

Asthma

ACTIVE_NOT_RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older at inclusion
* written informed consent
* currently diagnosed with Asthma fulfilling at least one of the criteria of potential severe Asthma
* willing and able to complete the study questionnaire miniAQLQ

Exclusion Criteria

* biological Treatment for Asthma during the past 12 months
* participation in a clinical Trial within the last 3 months
* patients who are not able to read or write, who do not understand the nature of the study or the ICF or who are dependent from the investigator

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No